Rankings
▼
Calendar
GPCR FY 2025 Earnings — Structure Therapeutics Inc. Revenue & Financial Results | Market Cap Arena
GPCR
Structure Therapeutics Inc.
$3B
FY 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$4M
Operating Income
-$288M
Net Income
-$141M
EPS (Diluted)
$-2.40
Cash Flow
Operating Cash Flow
-$222M
Free Cash Flow
-$226M
Stock-Based Comp.
$29M
Balance Sheet
Total Assets
$1.6B
Total Liabilities
$68M
Stockholders' Equity
$1.5B
Cash & Equivalents
$800M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$4M
$0
—
Operating Income
-$288M
-$158M
-81.7%
Net Income
-$141M
-$123M
-15.2%
← Q4 2024
All Quarters
Q1 2025 →